Elsevier
The UK academic research landscape has undergone significant changes as research becomes more multidisciplinary and global in nature, while government policies are putting pressure on universities to be more accountable in their research performance. As an organization that is dedicated to improving scientific research outcomes, we at Elsevier believe it is crucial that we collaborate closely with UK universities and understand their key challenges in responding to this new reality. We would like to engage university vice-chancellors and provosts in a much-needed dialogue on the implications of UK government policies on their universities and how the research enterprise is evolving as a result. Through such an engagement, we hope to contribute to solutions that best address the challenges that lie ahead and ultimately help advance the frontiers of science.
Elsevier provides information solutions for the science and health communities. Working in partnership, Elsevier publishes more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include ScienceDirect, Scopus, Reaxys, MD Consult and Nursing Consult, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai’s Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).